Treatment Patterns, Glycemic Control & Bodyweight With Canagliflozin 300 Mg Versus GLP1RAs in Type II Diabetes Patients

Journal of Comparative Effectiveness Research - United Kingdom
doi 10.2217/cer-2019-0002
Full Text
Abstract

Available in full text

Categories
Health Policy
Date
Authors
Publisher

Future Medicine Ltd


Related search